Cargando…

Continuous evolution of SpCas9 variants compatible with non-G PAMs

The targeting scope of Streptococcus pyogenes Cas9 (SpCas9) and its engineered variants is largely restricted to protospacer-adjacent motif (PAM) sequences containing Gs. Here, we report the evolution of three new SpCas9 variants that collectively recognize NRNH PAMs (where R = A or G and H = A, C,...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Shannon M., Wang, Tina, Randolph, Peyton B., Arbab, Mandana, Shen, Max W., Huang, Tony P., Matuszek, Zaneta, Newby, Gregory A., Rees, Holly A., Liu, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145744/
https://www.ncbi.nlm.nih.gov/pubmed/32042170
http://dx.doi.org/10.1038/s41587-020-0412-8
_version_ 1783520048464265216
author Miller, Shannon M.
Wang, Tina
Randolph, Peyton B.
Arbab, Mandana
Shen, Max W.
Huang, Tony P.
Matuszek, Zaneta
Newby, Gregory A.
Rees, Holly A.
Liu, David R.
author_facet Miller, Shannon M.
Wang, Tina
Randolph, Peyton B.
Arbab, Mandana
Shen, Max W.
Huang, Tony P.
Matuszek, Zaneta
Newby, Gregory A.
Rees, Holly A.
Liu, David R.
author_sort Miller, Shannon M.
collection PubMed
description The targeting scope of Streptococcus pyogenes Cas9 (SpCas9) and its engineered variants is largely restricted to protospacer-adjacent motif (PAM) sequences containing Gs. Here, we report the evolution of three new SpCas9 variants that collectively recognize NRNH PAMs (where R = A or G and H = A, C, or T) using phage-assisted non-continuous evolution (PANCE), three new phage-assisted continuous evolution (PACE) strategies for DNA binding, and a secondary selection for DNA cleavage. The targeting capabilities of these evolved variants and SpCas9-NG were characterized in HEK293T cells using a library of 11,776 genomically integrated protospacer-sgRNA pairs containing all possible NNNN PAMs. The evolved variants mediate indel formation and base editing in human cells and enable the A•T-to-G•C base editing of a sickle-cell anemia mutation using a previously inaccessible CACC PAM. These new evolved SpCas9s, together with previously reported variants, in principle enable targeting the majority of NR PAM sequences and substantially reduce the fraction of genomic sites that are inaccessible by Cas9-based methods.
format Online
Article
Text
id pubmed-7145744
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-71457442020-08-10 Continuous evolution of SpCas9 variants compatible with non-G PAMs Miller, Shannon M. Wang, Tina Randolph, Peyton B. Arbab, Mandana Shen, Max W. Huang, Tony P. Matuszek, Zaneta Newby, Gregory A. Rees, Holly A. Liu, David R. Nat Biotechnol Article The targeting scope of Streptococcus pyogenes Cas9 (SpCas9) and its engineered variants is largely restricted to protospacer-adjacent motif (PAM) sequences containing Gs. Here, we report the evolution of three new SpCas9 variants that collectively recognize NRNH PAMs (where R = A or G and H = A, C, or T) using phage-assisted non-continuous evolution (PANCE), three new phage-assisted continuous evolution (PACE) strategies for DNA binding, and a secondary selection for DNA cleavage. The targeting capabilities of these evolved variants and SpCas9-NG were characterized in HEK293T cells using a library of 11,776 genomically integrated protospacer-sgRNA pairs containing all possible NNNN PAMs. The evolved variants mediate indel formation and base editing in human cells and enable the A•T-to-G•C base editing of a sickle-cell anemia mutation using a previously inaccessible CACC PAM. These new evolved SpCas9s, together with previously reported variants, in principle enable targeting the majority of NR PAM sequences and substantially reduce the fraction of genomic sites that are inaccessible by Cas9-based methods. 2020-02-10 2020-04 /pmc/articles/PMC7145744/ /pubmed/32042170 http://dx.doi.org/10.1038/s41587-020-0412-8 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Miller, Shannon M.
Wang, Tina
Randolph, Peyton B.
Arbab, Mandana
Shen, Max W.
Huang, Tony P.
Matuszek, Zaneta
Newby, Gregory A.
Rees, Holly A.
Liu, David R.
Continuous evolution of SpCas9 variants compatible with non-G PAMs
title Continuous evolution of SpCas9 variants compatible with non-G PAMs
title_full Continuous evolution of SpCas9 variants compatible with non-G PAMs
title_fullStr Continuous evolution of SpCas9 variants compatible with non-G PAMs
title_full_unstemmed Continuous evolution of SpCas9 variants compatible with non-G PAMs
title_short Continuous evolution of SpCas9 variants compatible with non-G PAMs
title_sort continuous evolution of spcas9 variants compatible with non-g pams
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145744/
https://www.ncbi.nlm.nih.gov/pubmed/32042170
http://dx.doi.org/10.1038/s41587-020-0412-8
work_keys_str_mv AT millershannonm continuousevolutionofspcas9variantscompatiblewithnongpams
AT wangtina continuousevolutionofspcas9variantscompatiblewithnongpams
AT randolphpeytonb continuousevolutionofspcas9variantscompatiblewithnongpams
AT arbabmandana continuousevolutionofspcas9variantscompatiblewithnongpams
AT shenmaxw continuousevolutionofspcas9variantscompatiblewithnongpams
AT huangtonyp continuousevolutionofspcas9variantscompatiblewithnongpams
AT matuszekzaneta continuousevolutionofspcas9variantscompatiblewithnongpams
AT newbygregorya continuousevolutionofspcas9variantscompatiblewithnongpams
AT reeshollya continuousevolutionofspcas9variantscompatiblewithnongpams
AT liudavidr continuousevolutionofspcas9variantscompatiblewithnongpams